3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 3
1
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Conditions
Breast Neoplasms
2315
Neoplasms
1678
Prostatic Neoplasms
1178
Lung Neoplasms
908
Colorectal Neoplasms
873
Carcinoma, Non-Small-Cell Lung
848
Leukemia, Myeloid, Acute
587
Pancreatic Neoplasms
568
Multiple Myeloma
542
Carcinoma, Hepatocellular
510
Brain Neoplasms
509
Neoplasm Metastasis
456
Head and Neck Neoplasms
454
Melanoma
410
Ovarian Neoplasms
404
Glioblastoma
397
Precursor Cell Lymphoblastic Leukemia-Lymphoma
390
Stomach Neoplasms
370
Uterine Cervical Neoplasms
355
Squamous Cell Carcinoma of Head and Neck
355
Rectal Neoplasms
336
Recurrence
332
Hematologic Neoplasms
323
Sarcoma
322
Colonic Neoplasms
316
Lymphoma
310
Triple Negative Breast Neoplasms
284
Urinary Bladder Neoplasms
279
Glioma
277
Carcinoma, Renal Cell
277
Interventions
Cabergoline
2
Dopamine Agonists
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Hyperprolactinemia
×
1 year
×
Clear all
NCT07463235
2026-03-13
SPARAGMOS
University of Sao Paulo General Hospital
Phase 3
Recruiting
70 enrolled
NCT07045935
2025-09-23
ProBOLIC
University Hospital, Basel, Switzerland
Phase 4
Recruiting
60 enrolled